The serine threonine kinase RIP3: lost and found
Michael J Morgan1, You-Sun Kim2
1Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA.
BMB Reports
|April 11, 2015
Summary
Receptor-interacting protein kinase-3 (RIPK3) is crucial for programmed necrosis. Its absence in many cancers, due to methylation, can be reversed with decitabine, potentially impacting cancer therapy.
Area of Science:
- Molecular Biology
- Cell Death Pathways
- Cancer Biology
Background:
- Receptor-interacting protein kinase-3 (RIPK3) mediates programmed necrosis, a non-apoptotic cell death pathway.
- Programmed necrosis involves plasma membrane rupture, immune system activation, and inflammation, distinct from apoptosis.
- RIPK3 deficiency is observed in numerous cancer cell lines, impacting cellular stress responses.
Purpose of the Study:
- To investigate the role of RIPK3 in cancer cell lines.
- To determine the mechanisms underlying RIPK3 loss in cancer.
- To explore therapeutic strategies for restoring RIPK3 expression.
Main Methods:
- Analysis of RIPK3 protein expression in cancer cell lines.
- Investigation of methylation-dependent gene silencing.
- Treatment of cancer cells with hypomethylating agents like decitabine.
Main Results:
- RIPK3 protein expression is frequently absent in cancer cell lines.
- Methylation-dependent silencing is a primary cause of RIPK3 loss.
- Decitabine treatment can restore RIPK3 expression in deficient cancer cells.
Conclusions:
- Loss of RIPK3 expression in cancer may result from epigenetic silencing.
- Restoring RIPK3 expression via hypomethylating agents is feasible.
- RIPK3 status has implications for cancer treatment response.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
6.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.5K
01:31Regulation of the Unfolded Protein Response
3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
01:07MAPK Signaling Cascades
9.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
01:20The JAK-STAT Signaling Pathway
14.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.1K
01:26Receptor Tyrosine Kinases
21.2K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.2K
01:24Small GTPases - Ras and Rho
5.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.8K